Health insurers have pledged a set of voluntary reforms aimed at simplifying the prior authorization process.

CMS has recently initiated a surge in off-cycle, unannounced site visits nationwide.

A DME supplier lives in a glass house. If the supplier is doing something it should not be doing, somebody knows about it.

There are plenty of opportunities to collect from patients legally without jeopardizing your PTAN, but you must know the rules.

In a recent press release, the DOJ announced that the United States had settled a civil fraud lawsuit against Gilead Sciences, a large pharmaceutical manufacturer.

Allegiance Group has partnered with WeInfuse, a software solution for infusion providers.